HCV RNA at 12 weeks after treatment can predict sustained virologic response in chronic hepatitis C patients treated with pegylated interferon and ribavirin

被引：0
|
作者：
Yang, Sun
Lee, Joon Hyoek
Gwak, Geum-Youn
Choi, Moon Seok
Koh, Kwang Cheol
Paik, Seung Woon
Yoo, Byung Chul
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A830 / A830
页数：1
相关论文
共 50 条
  • [1] HCV RNA at 12 weeks after treatment can predict sustained virologic response in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Lee, J. H.
    Yoo, B. C.
    Lee, J. S.
    Kim, H. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A263 - A263
  • [2] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
  • [3] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [4] Vitamin D and B12 Supplementation and Sustained Virologic Response in Chronic Hepatitis C Patients Treated With Pegylated Interferon and Ribavirin
    Mihai, Catalina
    Dranga, Mihaela
    Drug, Vasile
    Prelipcean, Cristina Cijevschi
    GASTROENTEROLOGY, 2014, 146 (05) : S982 - S982
  • [5] Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin
    Paradis, Valerie
    Asselah, Tarik
    Dargere, Delphine
    Ripault, Marie-Pierre
    Martinot, Michele
    Boyer, Nathalie
    Valla, Dominique
    Marcellin, Patrick
    Bedossa, Pierre
    GASTROENTEROLOGY, 2006, 130 (07) : 2189 - 2197
  • [6] High ribavirin dose and extended treatment can raise sustained virologic response in chronic hepatitis C genotype 1 patients treated with simeprevir, pegylated interferon plus ribavirin
    Tahata, Yuki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Morishita, Naoki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Saji, Yukiko
    Doi, Yoshinori
    Hagiwara, Hideki
    Kaneko, Akira
    Fukui, Hiroyuki
    Inada, Masami
    Katayama, Kazuhiro
    Inoue, Atsuo
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2015, 62 : 804A - 804A
  • [7] HCV genotype does not predict sustained virologic response to interferon plus ribavirin in chronic hepatitis C patients with advanced fibrosis
    Cheinquer, H
    Coelho-Borges, S
    Cheinquer, N
    Sander, G
    Rezende, V
    Hadlich, E
    Stifft, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 230 - 230
  • [8] Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C
    Christensen, Peer Brehm
    Krarup, Henrik Bygum
    Laursen, Alex Lund
    Madsen, Poul Henning
    Pedersen, Court
    Schlichting, Poul
    Orholm, Marianne
    Ring-Larsen, Helmer
    Bukh, Jens
    Krogsgaard, Kim
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (8-9) : 1115 - 1119
  • [9] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [10] Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?
    Cheinquer, N
    Cheinquer, H
    Coelho-Borges, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 103 - 103
12345